Design, synthesis and evaluation of peroxisome proliferator-activated receptor α/γ dual agonists for the treatment of type 2 diabetes

被引：0

作者：

Das, Saibal Kumar ^{[1
]}

Abbineni, Chandrasekhar ^{[1
]}

Rao, Krovvidi Venkata Lakshmi Narasimha ^{[1
]}

Iqbal, Javed ^{[1
]}

Babu, Ravi Krishna ^{[1
]}

Chakrabarti, Ranjan ^{[1
]}

机构：

[1] Dr Reddys Labs Ltd, Metab Disorders Grp, Discovery Res, Hyderabad 500049, Andhra Pradesh, India

来源：

LETTERS IN DRUG DESIGN & DISCOVERY | 2007年 / 4卷 / 01期

关键词：

PPAR; diabetes; synthesis; ethyl 3-(4-aminophenyl)-2-ethoxypropionate; dyslipidemia and plasma glucose;

D O I：

暂无

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The design, synthesis and evaluation of several dual PPAR alpha/gamma agonists with three different heterocycles, viz. pyrazolo[4,3-d]pyrimidin-7-one, quinazolin-4-one and benzo[e][1,3]oxazine-4-one for the treatment of type 2 diabetes and associated dyslipidemia are described. Among them, compound 5cb was found to possess a potent dual PPAR alpha/gamma agonist property. It significantly reversed diabetic hyperglycemia while improving overall lipid homeostasis in preclinical animal models.

引用

页码：27 / 32

页数：6

共 50 条

[31] Peroxisome proliferator-activated receptor gamma agonists: Their role as vasoprotective agents in diabetes
Blaschke, Florian
Caglayan, Evren
Hsueh, Willa A.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2006, 35 (03) : 561 - +
[32] Peroxisome proliferator-activated receptor γ in diabetes and metabolism
Rangwala, SM
Lazar, MA
TRENDS IN PHARMACOLOGICAL SCIENCES, 2004, 25 (06) : 331 - 336
[33] Selective peroxisome proliferator-activated receptora modulators (SPPARMα): The next generation of peroxisome proliferator-activated receptor α-agonists
Fruchart, Jean-Charles
CARDIOVASCULAR DIABETOLOGY, 2013, 12
[34] Design Novel Dual Agonists for Treating Type-2 Diabetes by Targeting Peroxisome Proliferator-Activated Receptors with Core Hopping Approach
Ma, Ying
Wang, Shu-Qing
Xu, Wei-Ren
Wang, Run-Ling
Chou, Kuo-Chen
PLOS ONE, 2012, 7 (06):
[35] From Dual Peroxisome Proliferator Activated Receptor Agonists to Selective Peroxisome Proliferator Activated Receptor Modulators
Dagdelen, Selcuk
RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY, 2008, 2 (01) : 24 - 28
[36] Design, synthesis, and evaluation of a novel series of α-substituted phenylpropanoic acid derivatives as human peroxisome proliferator-activated receptor (PPAR) α/δ dual agonists for the treatment of metabolic syndrome
Kasuga, Jun-ichi
Yamasaki, Daisuke
Araya, Yoko
Nakagawa, Aya
Makishima, Makoto
Doi, Takefumi
Hashimoto, Yuichi
Miyachi, Hiroyuki
BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (24) : 8405 - 8414
[37] Dual peroxisome proliferator-activated receptor α/δ agonists: Hope for the treatment of alcohol-associated liver disease?
Zhang, Xin-Yang
Chen, Qin-Jun-Jie
Zhu, Feng
Li, Min
Shang, Dan
WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (37)
[38] Design, Synthesis, and Biological Evaluation of Novel Constrained meta-Substituted Phenyl Propanoic Acids as Peroxisome Proliferator-Activated Receptor α and γ Dual Agonists
Suh, Young-Ger
Kim, Nam-Jung
Koo, Bon-Woong
Lee, Kwang-Ok
Moon, Sung-Hyun
Shin, Dong-Hyung
Jung, Jong-Wha
Paek, Seung-Mann
Chang, Dong-Jo
Li, Funan
Kang, Hyun-Jin
Le, Tuong Vy Thi
Chae, Yu Na
Shin, Chang Yell
Kim, Mi-Kyung
Lim, Joong In
Ryu, Jae-Sang
Park, Hyun-Ju
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (20) : 6318 - 6333
[39] Recent Updates on Peroxisome Proliferator-Activated Receptor Agonists for the Treatment of Metabolic Syndrome
Grewal, Ajmer S.
Beniwal, Meenu
Pandita, Deepti
Sekhon, Bhupinder S.
Lather, Viney
MEDICINAL CHEMISTRY, 2016, 12 (01) : 3 - 21
[40] Design, synthesis, and biological evaluation of a series of alkoxy-3-indolylacetic acids as peroxisome proliferator-activated receptor γ/δ agonists
Gim, Hyo Jin
Li, Hua
Jeong, Ji Hye
Lee, Su Jeong
Sung, Mi-Kyung
Song, Mi-Young
Park, Byung-Hyun
Oh, Soo Jin
Ryu, Jae-Ha
Jeon, Raok
BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (13) : 3322 - 3336

← 1 2 3 4 5 →